Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

Journal of Viral Hepatitis

Volumn 15, Issue 11, 2008, Pages 782-789

  Echeverria I ^a   Zabaleta, A ^a   Silva, L ^a   Diaz Valdes N ^a   Riezu Boj, J I ^a   Lasarte, J J ^a   Borras Cuesta F ^a   Civeira, M P ^a,b   Prieto, J ^a,b   Sarobe, P ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Dendritic cells; Hepatitis C virus; Poly (I:C); Vaccine

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; NONSTRUCTURAL PROTEIN 3; POLYINOSINIC POLYCYTIDYLIC ACID; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 3; VIRUS PROTEIN; VIRUS RNA;

ADENOVIRUS; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE ACTIVATION; MALE; MIXED LYMPHOCYTE REACTION; MONOCYTE DERIVED DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VACCINATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADULT; AGED; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HLA-DR ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; POLY I-C; TOLL-LIKE RECEPTOR 3; TRANSDUCTION, GENETIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 54849427726     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01020.x     Document Type: Article

References (47)

1. Cerny A, McHutchison JG, Pasquinelli C et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995 95 : 521 530.
2. Lasarte JJ, Garcia Granero M, Lopez A et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 1998 28 : 815 822.
3. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996 98 : 1432 1440.
4. Sarobe P, Jauregui JI, Lasarte JJ et al. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment. J Hepatol 1996 25 : 1 9.
5. Diepolder HM, Zachoval R, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 : 1006 1007.
6. Gruener NH, Gerlach TJ, Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000 181 : 1528 1536.
7. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996 98 : 706 714.
8. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 1406.
9. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
10. Anthony DD, Yonkers NL, Post AB et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 2004 172 : 4907 4916.
11. Kanto T, Inoue M, Miyatake H et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004 190 : 1919 1926.
12. Wertheimer AM, Bakke A, Rosen HR. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 2004 40 : 335 345.
13. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 2005 192 : 497 503.
14. Piccioli D, Tavarini S, Nuti S et al. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 2005 42 : 61 67.
15. Rodrigue-Gervais IG, Jouan L, Beaule G et al. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 2007 81 : 5537 5546.
16. Decalf J, Fernandes S, Longman R et al. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007 204 : 2423 2437.
17. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004 104 : 2235 2246.
18. Garcia F, Lejeune M, Climent N et al. Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis 2005 191 : 1680 1685.
19. Lu W, Arraes LC, Ferreira WT, Andrieu JM. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 2004 10 : 1359 1365.
20. Lai WK, Curbishley SM, Goddard S et al. Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J Hepatol 2007 47 : 338 347.
21. Kanto T, Hayashi N, Takehara T et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999 162 : 5584 5591.
22. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001 97 : 3171 3176.
23. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001 120 : 512 524.
24. Larsson M, Babcock E, Grakoui A et al. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol 2004 78 : 6151 6161.
25. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004 103 : 1026 1029.
26. Gelderblom HC, Nijhuis LE, de Jong EC et al. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile. Liver Int 2007 27 : 944 953.
27. Zabaleta A, Llopiz D, Arribillaga L et al. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein. Mol Ther 2008 16 : 210 217.
28. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 413 : 732 738.
29. Arribillaga L, de Cerio AL, Sarobe P et al. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine 2002 21 : 202 210.
30. Bruna-Romero O, Lasarte JJ, Wilkinson G et al. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 1997 25 : 470 477.
31. Rodriguez-Lopez M, Riezu-Boj JI, Ruiz M et al. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J Gen Virol 1999 80 (Pt 3 727 738.
32. van Leeuwen HC, Reusken CB, Roeten M et al. Evolution of naturally occurring 5′ non-translated region variants of hepatitis C virus genotype 1b in selectable replicons. J Gen Virol 2004 85 : 1859 1866.
33. Nattermann J, Zimmermann H, Iwan A et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 2006 44 : 945 954.
34. Hokey DA, Larregina AT, Erdos G, Watkins SC, Falo Jr LD. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Res 2005 65 : 10059 10067.
35. Li W, Krishnadas DK, Li J, Tyrrell DL, Agrawal B. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy. J Immunol 2006 176 : 6065 6075.
36. Sarobe P, Lasarte JJ, Zabaleta A et al. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 2003 77 : 10862 10871.
37. Sarobe P, Lasarte JJ, Casares N et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 2002 76 : 5062 5070.
38. Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003 33 : 3448 3457.
39. Dolganiuc A, Chang S, Kodys K et al. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 2006 177 : 6758 6768.
40. Averill L, Lee WM, Karandikar NJ. Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol 2007 123 : 40 49.
41. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 2004 137 : 559 565.
42. Barnes E, Salio M, Cerundolo V et al. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus. J Viral Hepat 2008 15 : 219 228.
43. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 : 449 458.
44. Fan XG, Liu WE, Li CZ et al. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm 1998 7 : 295 297.
45. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 1996 24 : 6 9.
46. Rogge L, D'Ambrosio D, Biffi M et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998 161 : 6567 6574.
47. Fan Z, Huang XL, Kalinski P, Young S, Rinaldo Jr CR. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2007 14 : 1127 1137.